1. Home
  2. CGNX vs KYMR Comparison

CGNX vs KYMR Comparison

Compare CGNX & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cognex Corporation

CGNX

Cognex Corporation

HOLD

Current Price

$58.38

Market Cap

6.0B

Sector

Industrials

ML Signal

HOLD

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$84.09

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CGNX
KYMR
Founded
1981
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
6.4B
IPO Year
1989
2020

Fundamental Metrics

Financial Performance
Metric
CGNX
KYMR
Price
$58.38
$84.09
Analyst Decision
Buy
Strong Buy
Analyst Count
11
24
Target Price
$46.45
$105.96
AVG Volume (30 Days)
1.9M
738.5K
Earning Date
02-11-2026
02-26-2026
Dividend Yield
0.79%
N/A
EPS Growth
9.80
N/A
EPS
0.68
N/A
Revenue
$994,359,000.00
$43,735,000.00
Revenue This Year
$9.46
$18.36
Revenue Next Year
$6.79
N/A
P/E Ratio
$63.28
N/A
Revenue Growth
8.73
N/A
52 Week Low
$22.67
$19.45
52 Week High
$49.76
$103.00

Technical Indicators

Market Signals
Indicator
CGNX
KYMR
Relative Strength Index (RSI) 84.83 65.66
Support Level $42.08 $76.52
Resistance Level $44.27 $78.91
Average True Range (ATR) 1.81 3.50
MACD 1.31 1.18
Stochastic Oscillator 94.23 99.43

Price Performance

Historical Comparison
CGNX
KYMR

About CGNX Cognex Corporation

Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. ID products read codes that have been applied to items during the manufacturing process. Cognex generates the maximum proportion of its sales in the United States and Europe.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Share on Social Networks: